|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000164176 |
Summary for EDIL3 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000164176 | Gene symbol | EDIL3 |
| Gene name | EGF like repeats and discoidin domains 3 | |
| HGNC | 3173 | |
| Entrez ID | 10085 | |
| Gene type | protein_coding | |
| Synonyms | EDIL3|DEL1 | |
| UniProtAcc | O43854 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for EDIL3 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| EDIL3 | 7.28e+03 | 1.26e+00 | 1.77e-01 | 7.11e+00 | 1.16e-12 | 3.66e-12 | KIRC |
| EDIL3 | 1.65e+03 | 1.48e+00 | 2.83e-01 | 5.22e+00 | 1.82e-07 | 7.61e-07 | HNSC |
| EDIL3 | 8.92e+02 | -1.35e+00 | 4.63e-01 | -2.92e+00 | 3.52e-03 | 9.80e-03 | BLCA |
| EDIL3 | 3.25e+03 | 1.21e+00 | 3.84e-01 | 3.14e+00 | 1.67e-03 | 3.38e-03 | KIRP |
| EDIL3 | 4.62e+02 | 2.92e+00 | 6.63e-01 | 4.41e+00 | 1.05e-05 | 5.85e-05 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| EDIL3 | 2.84e+03 | -1.01e+00 | 3.72e-01 | -2.73e+00 | 6.41e-03 | 1.23e-02 | LUSC |
| EDIL3 | 1.05e+03 | -2.61e+00 | 3.53e-01 | -7.39e+00 | 1.44e-13 | 8.42e-12 | READ |
Top |
Sex-biased somatic mutation for EDIL3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for EDIL3 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg07690181 | chr5:84383825 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.44e-01 | 3.29e-01 | -2.19e+00 | 2.84e-02 | 4.00e-02 | -1.86e-01 |
| BRCA | cg11559250 | chr5:84383305 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.74e-01 | 3.53e-01 | -2.28e+00 | 2.23e-02 | 3.65e-02 | -1.79e-01 |
| BRCA | cg07201620 | chr5:84384123 | CGI:chr5:84383766-84384785 | promoter,gene body | 3.27e-01 | 6.12e-01 | -2.93e+00 | 3.41e-03 | 1.74e-02 | -2.85e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg07201620 | chr5:84384123 | CGI:chr5:84383766-84384785 | promoter,gene body | 2.43e-01 | 8.28e-02 | 5.00e+00 | 5.86e-07 | 2.29e-06 | 1.61e-01 |
| KIRC | cg24988625 | chr5:84384248 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.42e-01 | 3.91e-02 | 5.88e+00 | 4.16e-09 | 3.59e-08 | 1.03e-01 |
| KIRC | cg19722082 | chr5:84385745 | CGI:chr5:84383766-84384785 | promoter | 5.60e-01 | 7.94e-01 | -2.34e+00 | 1.91e-02 | 2.12e-02 | -2.33e-01 |
| HNSC | cg07201620 | chr5:84384123 | CGI:chr5:84383766-84384785 | promoter,gene body | 2.10e-01 | 9.82e-02 | 3.04e+00 | 2.36e-03 | 3.76e-03 | 1.12e-01 |
| LUSC | cg01072952 | chr5:84383546 | CGI:chr5:84383766-84384785 | promoter,gene body | 3.51e-01 | 2.36e-01 | 2.62e+00 | 8.82e-03 | 1.26e-02 | 1.15e-01 |
| BLCA | cg07690181 | chr5:84383825 | CGI:chr5:84383766-84384785 | promoter,gene body | 2.76e-01 | 5.94e-02 | 2.30e+00 | 2.12e-02 | 2.56e-02 | 2.17e-01 |
| BLCA | cg15716405 | chr5:84384872 | CGI:chr5:84383766-84384785 | promoter | 1.20e-01 | 1.55e-02 | 2.39e+00 | 1.69e-02 | 2.14e-02 | 1.05e-01 |
| BLCA | cg11559250 | chr5:84383305 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.69e-01 | 5.60e-02 | 2.09e+00 | 3.65e-02 | 3.91e-02 | 1.13e-01 |
| BLCA | cg07201620 | chr5:84384123 | CGI:chr5:84383766-84384785 | promoter,gene body | 3.72e-01 | 1.39e-01 | 2.52e+00 | 1.19e-02 | 1.62e-02 | 2.33e-01 |
| BLCA | cg03478689 | chr5:84384899 | CGI:chr5:84383766-84384785 | promoter | 1.84e-01 | 6.91e-02 | 2.06e+00 | 3.96e-02 | 4.17e-02 | 1.15e-01 |
| LIHC | cg19722082 | chr5:84385745 | CGI:chr5:84383766-84384785 | promoter | 5.40e-01 | 7.49e-01 | 2.87e+00 | 4.15e-03 | 5.60e-03 | -2.09e-01 |
| CHOL | cg01072952 | chr5:84383546 | CGI:chr5:84383766-84384785 | promoter,gene body | 5.51e-01 | 3.88e-01 | 2.14e+00 | 3.25e-02 | 3.87e-02 | 1.62e-01 |
| CHOL | cg17559809 | chr5:84385150 | CGI:chr5:84383766-84384785 | promoter | 3.07e-01 | 1.35e-01 | 2.14e+00 | 3.25e-02 | 3.87e-02 | 1.72e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg07690181 | chr5:84383825 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.44e-01 | 2.89e-02 | 9.45e+00 | 3.36e-21 | 2.01e-20 | 1.15e-01 |
| BRCA | cg11559250 | chr5:84383305 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.74e-01 | 5.17e-02 | 8.78e+00 | 1.63e-18 | 7.82e-18 | 1.22e-01 |
| BRCA | cg04512917 | chr5:84383393 | CGI:chr5:84383766-84384785 | promoter,gene body | 2.98e-01 | 1.61e-01 | 6.03e+00 | 1.66e-09 | 3.95e-09 | 1.37e-01 |
| BRCA | cg01072952 | chr5:84383546 | CGI:chr5:84383766-84384785 | promoter,gene body | 5.09e-01 | 2.87e-01 | 1.22e+01 | 2.01e-34 | 5.36e-33 | 2.22e-01 |
| BRCA | cg07201620 | chr5:84384123 | CGI:chr5:84383766-84384785 | promoter,gene body | 3.27e-01 | 1.02e-01 | 1.00e+01 | 1.06e-23 | 7.94e-23 | 2.26e-01 |
| BRCA | cg17559809 | chr5:84385150 | CGI:chr5:84383766-84384785 | promoter | 2.83e-01 | 1.79e-01 | 4.20e+00 | 2.65e-05 | 4.24e-05 | 1.04e-01 |
| LUAD | cg16099804 | chr5:84384435 | CGI:chr5:84383766-84384785 | UTR,promoter,exon,gene body | 1.44e-01 | 2.41e-02 | 3.62e+00 | 2.94e-04 | 1.50e-03 | 1.20e-01 |
| LUAD | cg24988625 | chr5:84384248 | CGI:chr5:84383766-84384785 | promoter,gene body | 1.63e-01 | 5.44e-02 | 3.48e+00 | 5.06e-04 | 2.07e-03 | 1.09e-01 |
| LUAD | cg16773899 | chr5:84384508 | CGI:chr5:84383766-84384785 | UTR,promoter,exon,gene body | 1.81e-01 | 8.11e-02 | 3.16e+00 | 1.60e-03 | 4.37e-03 | 1.00e-01 |
| LUAD | cg03478689 | chr5:84384899 | CGI:chr5:84383766-84384785 | promoter | 1.48e-01 | 4.69e-02 | 4.22e+00 | 2.48e-05 | 6.37e-04 | 1.01e-01 |
| COAD | cg19722082 | chr5:84385745 | CGI:chr5:84383766-84384785 | promoter | 5.63e-01 | 3.96e-01 | 2.66e+00 | 7.79e-03 | 1.31e-02 | 1.67e-01 |
Top |
Exon skipping events with PSI in TCGA for EDIL3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for EDIL3 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for EDIL3 |
| TFs related to EDIL3. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | DMRTA1 | EDIL3 | 3.56e+00 | 5.61e-03 | 4.64e+00 | 9.90e-01 | Female-biased |
| CHOL | DMRTA2 | EDIL3 | 3.68e+00 | 8.85e-03 | 4.64e+00 | 9.86e-01 | Female-biased |
| CHOL | FOXA1 | EDIL3 | 3.27e+00 | 6.98e-03 | 4.28e+00 | 9.85e-01 | Female-biased |
| CHOL | FOXA3 | EDIL3 | 3.37e+00 | 1.00e-02 | 4.30e+00 | 9.82e-01 | Female-biased |
| CHOL | FOXB1 | EDIL3 | 3.31e+00 | 6.14e-03 | 4.36e+00 | 9.87e-01 | Female-biased |
| CHOL | LHX2 | EDIL3 | 4.14e+00 | 1.48e-02 | 4.98e+00 | 9.82e-01 | Female-biased |
| CHOL | MSX1 | EDIL3 | 3.35e+00 | 7.24e-03 | 4.37e+00 | 9.86e-01 | Female-biased |
| CHOL | MSX2 | EDIL3 | 3.38e+00 | 9.18e-03 | 4.33e+00 | 9.83e-01 | Female-biased |
| CHOL | TBP | EDIL3 | 3.29e+00 | 5.54e-03 | 4.37e+00 | 9.87e-01 | Female-biased |
| CHOL | ZNF25 | EDIL3 | 3.19e+00 | 5.24e-03 | 4.28e+00 | 9.87e-01 | Female-biased |
| CHOL | ZNF418 | EDIL3 | 2.94e+00 | 2.19e-03 | 4.25e+00 | 9.89e-01 | Female-biased |
| DLBC | DMRTA1 | EDIL3 | 3.03e+00 | 2.67e-03 | 4.28e+00 | 9.88e-01 | Female-biased |
| DLBC | DMRTA2 | EDIL3 | 3.14e+00 | 3.48e-03 | 4.32e+00 | 9.88e-01 | Female-biased |
| DLBC | LHX2 | EDIL3 | 3.66e+00 | 1.29e-02 | 4.49e+00 | 9.80e-01 | Female-biased |
| DLBC | SKOR1 | EDIL3 | 3.53e+00 | 6.43e-03 | 4.55e+00 | 9.87e-01 | Female-biased |
| DLBC | SKOR2 | EDIL3 | 3.64e+00 | 7.64e-03 | 4.61e+00 | 9.87e-01 | Female-biased |
| DLBC | ZNF418 | EDIL3 | 1.16e+00 | 3.20e-05 | 3.87e+00 | 9.82e-01 | Female-biased |
| ESCA | DNMT1 | EDIL3 | 4.17e+00 | 9.90e-01 | 2.89e+00 | 4.01e-04 | Male-biased |
| ESCA | ZNF100 | EDIL3 | 3.91e+00 | 9.81e-01 | 3.05e+00 | 4.25e-03 | Male-biased |
| ESCA | ZNF783 | EDIL3 | 4.15e+00 | 9.85e-01 | 3.33e+00 | 5.56e-03 | Male-biased |
| GBM | MXI1 | EDIL3 | 2.66e+00 | 4.00e-03 | 4.06e+00 | 9.83e-01 | Female-biased |
| GBM | ZBTB14 | EDIL3 | 3.30e+00 | 9.47e-03 | 4.37e+00 | 9.83e-01 | Female-biased |
| GBM | ZNF707 | EDIL3 | 2.20e+00 | 1.80e-03 | 3.90e+00 | 9.80e-01 | Female-biased |
| SKCM | DMRTA1 | EDIL3 | 4.83e+00 | 9.88e-01 | 3.49e+00 | 4.32e-03 | Male-biased |
| SKCM | DMRTA2 | EDIL3 | 4.94e+00 | 9.89e-01 | 3.56e+00 | 3.84e-03 | Male-biased |
| SKCM | FOXA1 | EDIL3 | 4.40e+00 | 9.85e-01 | 2.74e+00 | 1.48e-03 | Male-biased |
| SKCM | FOXA3 | EDIL3 | 4.48e+00 | 9.86e-01 | 2.84e+00 | 1.62e-03 | Male-biased |
| SKCM | FOXB1 | EDIL3 | 4.56e+00 | 9.87e-01 | 2.90e+00 | 1.55e-03 | Male-biased |
| SKCM | LHX2 | EDIL3 | 5.23e+00 | 9.86e-01 | 4.18e+00 | 1.02e-02 | Male-biased |
| SKCM | MSX1 | EDIL3 | 4.78e+00 | 9.88e-01 | 3.40e+00 | 3.78e-03 | Male-biased |
| SKCM | MSX2 | EDIL3 | 4.76e+00 | 9.88e-01 | 3.34e+00 | 3.28e-03 | Male-biased |
| SKCM | NANOG | EDIL3 | 4.50e+00 | 9.85e-01 | 3.07e+00 | 3.13e-03 | Male-biased |
| SKCM | SKOR1 | EDIL3 | 5.20e+00 | 9.89e-01 | 4.01e+00 | 6.74e-03 | Male-biased |
| SKCM | SKOR2 | EDIL3 | 5.20e+00 | 9.87e-01 | 4.12e+00 | 9.06e-03 | Male-biased |
| SKCM | TBP | EDIL3 | 4.44e+00 | 9.80e-01 | 3.26e+00 | 6.57e-03 | Male-biased |
| SKCM | ZNF25 | EDIL3 | 4.51e+00 | 9.88e-01 | 2.58e+00 | 5.76e-04 | Male-biased |
| SKCM | ZNF418 | EDIL3 | 4.39e+00 | 9.86e-01 | 1.50e+00 | 2.19e-05 | Male-biased |
| EDIL3 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for EDIL3 |
| RBPs related to ES in EDIL3. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ESCA | MSI1 | exon_skip_443084 | 1.63e+01 | 2.98e-03 | 1.69e+01 | 9.97e-01 | Female-biased |
| EDIL3 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000164176 | GORAB-AS1,hsa-mir-132,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | AC078785.1,hsa-mir-132,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | GORAB-AS1,hsa-mir-212,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | AC078785.1,hsa-mir-212,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | LINC01094,hsa-mir-340,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | RASSF8-AS1,hsa-mir-340,EDIL3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000164176 | MAGI2-AS3,hsa-mir-205,EDIL3 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000164176 | MAGI2-AS3,hsa-mir-216b,EDIL3 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000164176 | AL137026.1,hsa-mir-496,EDIL3 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000164176 | B3GALT5-AS1,hsa-mir-340,EDIL3 | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000164176 | LINC00461,hsa-mir-340,EDIL3 | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000164176 | AC099521.1,hsa-mir-340,EDIL3 | Male-specific ceRNA | TCGA-KIRP |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs79290755 | chr5:93071268:C:A | - | 0.180681664438405 | 0.00646256402742797 | HNSC | Female-baised eQTL |
| rs11948487 | chr5:93039525:T:C | - | 0.156469757721403 | 0.0368064958081199 | HNSC | Female-baised eQTL |
| rs3916011 | chr5:81473391:A:G | - | 0.0596242507646856 | 0.0456078504356546 | LUSC | Female-baised eQTL |
| rs17508283 | chr5:89391697:G:A | - | 0.0640521348087518 | 0.0285104324887798 | LUAD | Female-baised eQTL |
| rs2909868 | chr5:86221450:G:C | - | -0.0326521950730025 | 0.0431922580048918 | LUAD | Female-baised eQTL |
| rs1358555 | chr5:89452635:T:C | - | 0.0614550338226363 | 0.0435227211353426 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2431222 | chr5:80591672:T:G | - | 0.0820715375922654 | 0.0429795859884353 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000164176 |
| CpG Site: cg19722082 | |
| Position to Gene: promoter | |
| Male Effect: -0.244401778308192 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg19722082 | chr5:84385745 | promoter | -0.244401778308192 | 5.2249812803474e-06 | -0.491606329045003 | 2.2074141620269732e-13 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of EDIL3 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000164176 | EDIL3 | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
| ENSG00000164176 | EDIL3 | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
